Northern Capital Management (Wisconsin)’s Kindred Biosciences, Inc. KIN Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-26,050	Closed	-$89K	–	153
2015 Q4	$89K	Hold	26,050	–	–	0.04%	146
2015 Q3	$135K	Buy	26,050 +125	+0.5%	+$771	0.06%	146
2015 Q2	$177K	Hold	25,925	–	–	0.08%	134
2015 Q1	$185K	Buy	25,925 +6,925	+36%	+$47.7K	0.09%	137
2014 Q4	$142K	Buy	19,000 +475	+3%	+$4.03K	0.07%	138
2014 Q3	$171K	Buy	+18,525	New	+$250K	0.09%	134

Other funds holding KIN

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s KIN Position: Q1 2016 in Review

Northern Capital Management (Wisconsin) sold out of Kindred Biosciences, Inc. (KIN) in Q1 2016, closing a stake of 26,050 shares — an estimated $89K sold.

Northern Capital Management (Wisconsin) first reported a position in KIN in Q3 2014 and held it in 6 quarters. The position peaked at $185K in Q1 2015. 44 funds tracked by Wall St. Rank hold KIN as of Q1 2016.

Northern Capital Management (Wisconsin) reported no remaining Kindred Biosciences, Inc. position as of Q1 2016 after selling out during the quarter.
Northern Capital Management (Wisconsin) sold 26,050 Kindred Biosciences, Inc. shares in Q1 2016, an estimated $89K.
Northern Capital Management (Wisconsin) first reported a position in Kindred Biosciences, Inc. in Q3 2014 and held it in 6 quarters.
Northern Capital Management (Wisconsin)'s Kindred Biosciences, Inc. position peaked at $185K in Q1 2015.
44 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2016.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q1 2016, filed 6 May 2016.